Gökçe Simsek1, Burak Mustafa Taş2, Nuray Bayar Muluk3, Musa Azman3, Rahmi Kılıç3. 1. Division of Head and Neck Surgery, Department of Otorhinolaryngology, Kırıkkale University School of Medicine, Kirikkale, Turkey. entsurgeon@rocketmail.com. 2. Division of Head and Neck Surgery, Department of Otorhinolaryngology, Kırıkkale Yuksek Ihtısas Hospital, Kirikkale, Turkey. 3. Division of Head and Neck Surgery, Department of Otorhinolaryngology, Kırıkkale University School of Medicine, Kirikkale, Turkey.
Abstract
PURPOSE: The main aim of this study was to compare the efficacy of intratympanic administration of dexamethasone and resveratrol in preventing cisplatin ototoxicity by measuring acoustic brainstem response (ABR) and distortion product otoacoustic emission (DPOAE). METHODS: Forty rats (80 ears) were divided into five groups. Cisplatin was administered intraperitoneally to the first group (n = 8). Group 2 (n = 8) received cisplatin after resveratrol had been administered intratympanically. Group 3 (n = 8) received cisplatin after dexamethasone had been administered intratympanically. Group 4 (n = 8) received cisplatin after sodium chloride (NaCl) had been given intratympanically. Group 5 (n = 8) received cisplatin after dimethylsulfoxide (DMSO) had been given intratympanically. ABR and DPOAE tests were performed on all groups before and 72 h after the procedure. RESULTS: ABR threshold values in rats that received dexamethasone and resveratrol were found to be less affected than those observed in the other post-cisplatin groups. ABR-IV and ABR-I-IV interval values were significantly reduced in rats that had been given dexamethasone and resveratrol compared to the other groups. After cisplatin treatment, otoacoustic emission (OAE) amplitudes were significantly decreased in Groups 1, 4, and 5 for all frequencies, while OAE values were sustained in the resveratrol and dexamethasone groups (Groups 2 and 3). At OAE frequency 5652, dexamethasone was more significantly associated with protective than resveratrol was, while no significant difference was found between the two groups at other OAE frequencies. CONCLUSION: In conclusion, intratympanic dexamethasone and intratympanic resveratrol treatments may provide a significant protection against cisplatin-induced ototoxicity.
PURPOSE: The main aim of this study was to compare the efficacy of intratympanic administration of dexamethasone and resveratrol in preventing cisplatinototoxicity by measuring acoustic brainstem response (ABR) and distortion product otoacoustic emission (DPOAE). METHODS: Forty rats (80 ears) were divided into five groups. Cisplatin was administered intraperitoneally to the first group (n = 8). Group 2 (n = 8) received cisplatin after resveratrol had been administered intratympanically. Group 3 (n = 8) received cisplatin after dexamethasone had been administered intratympanically. Group 4 (n = 8) received cisplatin after sodium chloride (NaCl) had been given intratympanically. Group 5 (n = 8) received cisplatin after dimethylsulfoxide (DMSO) had been given intratympanically. ABR and DPOAE tests were performed on all groups before and 72 h after the procedure. RESULTS: ABR threshold values in rats that received dexamethasone and resveratrol were found to be less affected than those observed in the other post-cisplatin groups. ABR-IV and ABR-I-IV interval values were significantly reduced in rats that had been given dexamethasone and resveratrol compared to the other groups. After cisplatin treatment, otoacoustic emission (OAE) amplitudes were significantly decreased in Groups 1, 4, and 5 for all frequencies, while OAE values were sustained in the resveratrol and dexamethasone groups (Groups 2 and 3). At OAE frequency 5652, dexamethasone was more significantly associated with protective than resveratrol was, while no significant difference was found between the two groups at other OAE frequencies. CONCLUSION: In conclusion, intratympanic dexamethasone and intratympanic resveratrol treatments may provide a significant protection against cisplatin-induced ototoxicity.
Authors: Fernando García-Alcántara; Silvia Murillo-Cuesta; Sara Pulido; Jose M Bermúdez-Muñoz; Raquel Martínez-Vega; Marta Milo; Isabel Varela-Nieto; Teresa Rivera Journal: Hear Res Date: 2017-12-14 Impact factor: 3.208
Authors: Christine T Dinh; Si Chen; John Dinh; Stefania Goncalves; Esperanza Bas; Kyle Padgett; Perry Johnson; Nagy Elsayyad; Fred Telischi; Thomas Van De Water Journal: Otol Neurotol Date: 2017-02 Impact factor: 2.311
Authors: Se Hee Lee; Hyung Sub Kim; Yun Suk An; Jiwon Chang; June Choi; Gi Jung Im Journal: Int J Pediatr Otorhinolaryngol Date: 2014-11-15 Impact factor: 1.675
Authors: Anna I Petridou; Eleftheria T Zagora; Petros Petridis; George S Korres; Maria Gazouli; Ioannis Xenelis; Efthymios Kyrodimos; Georgia Kontothanasi; Andriana C Kaliora Journal: Nutrients Date: 2019-12-12 Impact factor: 5.717